Liquid Biopsy and NICD Market Comprehensive Statistics, Growth Rate, and Future Trends 2035
The Liquid Biopsy and Non-Invasive Cancer Diagnostics (NICD) Market represents a paradigm shift in oncology, replacing or complementing invasive tissue biopsies with blood, urine, and bodily fluid assays. By detecting circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and methylation patterns, liquid biopsy enables early cancer screening, minimal residual disease (MRD)...
0 التعليقات 0 المشاركات 25 مشاهدة 0 معاينة